Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders??? Equity

v3.23.3
Condensed Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   886,860    
Beginning balance at Dec. 31, 2021 $ 72,770 $ 0 $ 187,510 $ (114,740)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Issuance of common shares, gross (in shares)   368,252    
Issuance of common shares, gross 23,400   23,400  
Issuance of common shares upon vesting RSUs (in shares)   8,248    
Stock option exercise (in shares)   3,870    
Stock option exercise 22   22  
Stock-based compensation expense 500   500  
Equity issuance costs (1,177)   (1,177)  
Beneficial conversion feature of Convertible Note 1,749   1,749  
Conversion of Convertible Note to common shares (in shares)   20,233    
Conversion of Convertible Note to common shares 1,324   1,324  
Net loss (16,140)     (16,140)
Ending balance (in shares) at Mar. 31, 2022   1,287,463    
Ending balance at Mar. 31, 2022 82,448 $ 0 213,328 (130,880)
Beginning balance (in shares) at Dec. 31, 2021   886,860    
Beginning balance at Dec. 31, 2021 72,770 $ 0 187,510 (114,740)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net loss (37,349)      
Ending balance (in shares) at Sep. 30, 2022   1,452,380    
Ending balance at Sep. 30, 2022 69,502 $ 0 221,591 (152,089)
Beginning balance (in shares) at Mar. 31, 2022   1,287,463    
Beginning balance at Mar. 31, 2022 82,448 $ 0 213,328 (130,880)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Issuance of common shares upon vesting RSUs (in shares)   1,330    
Stock option exercise (in shares)   1,186    
Stock-based compensation expense 1,148   1,148  
Conversion of Convertible Note to common shares (in shares)   30,000    
Conversion of Convertible Note to common shares 2,039   2,039  
Net loss (1,046)     (1,046)
Ending balance (in shares) at Jun. 30, 2022   1,319,979    
Ending balance at Jun. 30, 2022 84,589 $ 0 216,515 (131,926)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Issuance of common shares, gross (in shares)   131,573    
Issuance of common shares, gross 4,286   4,286  
Issuance of common shares upon vesting RSUs (in shares)   828    
Stock-based compensation expense 958   958  
Equity issuance costs (168)   (168)  
Net loss (20,163)     (20,163)
Ending balance (in shares) at Sep. 30, 2022   1,452,380    
Ending balance at Sep. 30, 2022 $ 69,502 $ 0 221,591 (152,089)
Beginning balance (in shares) at Dec. 31, 2022 1,454,559 1,454,559    
Beginning balance at Dec. 31, 2022 $ 40,408 $ 0 221,313 (180,905)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Issuance of common shares upon vesting RSUs (in shares)   12,350    
Stock-based compensation expense 468   468  
Equity issuance costs (25)   (25)  
Net loss (4,081)     (4,081)
Ending balance (in shares) at Mar. 31, 2023   1,466,909    
Ending balance at Mar. 31, 2023 $ 36,770 $ 0 221,756 (184,986)
Beginning balance (in shares) at Dec. 31, 2022 1,454,559 1,454,559    
Beginning balance at Dec. 31, 2022 $ 40,408 $ 0 221,313 (180,905)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Net loss $ (12,814)      
Ending balance (in shares) at Sep. 30, 2023 1,726,145 1,726,145    
Ending balance at Sep. 30, 2023 $ 29,689 $ 0 223,407 (193,718)
Beginning balance (in shares) at Mar. 31, 2023   1,466,909    
Beginning balance at Mar. 31, 2023 36,770 $ 0 221,756 (184,986)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Issuance of common shares, gross (in shares)   51,986    
Issuance of common shares, gross 438   438  
Issuance of common shares upon vesting RSUs (in shares)   4,587    
Stock-based compensation expense 433   433  
Equity issuance costs (97)   (97)  
Net loss (3,595)     (3,595)
Ending balance (in shares) at Jun. 30, 2023   1,523,482    
Ending balance at Jun. 30, 2023 33,949 $ 0 222,530 (188,581)
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Issuance of common shares, gross (in shares)   201,912    
Issuance of common shares, gross 903   903  
Issuance of common shares upon vesting RSUs (in shares)   738    
Stock-based compensation expense 52   52  
Equity issuance costs (77)   (77)  
Round off due to reverse split (in shares)   13    
Net loss $ (5,138)     (5,138)
Ending balance (in shares) at Sep. 30, 2023 1,726,145 1,726,145    
Ending balance at Sep. 30, 2023 $ 29,689 $ 0 $ 223,407 $ (193,718)